2nd International Conference on
Vaccines and Vaccination
August 20-22, 2012 Hilton Chicago/Northbrook, USA
Participants List from Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
Universidade Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
Universidade de Sao Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List From Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women's Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy's labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
2nd International Conference on Vaccines & Vaccination, Vaccines-2012 , will be organized around the theme "Prospects and Development of Prophylactic & Therapeutic Vaccines."
Vaccines-2012 is comprised of 9 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Vaccines.
Submit your abstract to any of the following tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Renowned Speakers
Gerardo Kaplan
FDA, USA
John Dong
GenPhar Inc, USA
Michael Vajdy
EpitoGenesis Inc, USA
Anne De Groot
EpiVax Inc, USA
Mark J Ahn
Galena Biopharma Inc, USA
Conrad F Mir
Genetic Immunity, USA
Maya Salnikova
Merck Inc, USA
Daming Zhu
National Institutes of Health, USA
Philip W. Askenase
Yale University School of Medicine, USA
Marc Bonneville
Inserm-Nantes University, France
Takashi Kei Kishimoto
Selecta Biosciences, USA
Eli Young
OpSaniTx, USA
Gavin Zealey
Sanofi Pasteur, USA
Gregory M. Glenn
Novavax, USA
Kei Amemiya
U.S. Army Medical Research Institute of Infectious Diseases, USA
Nizar Souayah
Director of EMG LAB & Peripheral Neuropathy Center, USA
De-chu Christopher Tang
Vaxin Inc, USA
Cecil Czerkinsky
The International Vaccine Institute, The Republic of Korea
Track 1: Vaccines and the Basic Immune System
Track 1-1
Innate and acquired immunity, attenuated, conjugated, toxoid, and subunit vaccines
Track 1-2
Vectors and cell-based vaccine delivering technology
Track 1-3
Development of immunity
Track 1-4
Vaccine characterization, formulation, and delivery: New challenges and strategies
Track 2: New Approaches for B and T Cells
Track 2-1
Response of B and T Cells to the pathogens
Track 2-2
New vaccine approaches
Track 2-3
Immunotherapy and chemo immunotherapy
Track 2-4
Nano and micro particles as adjuvants and delivery systems
Track 2-5
Macrophage model systems
Track 2-6
Targeted delivery approaches for vaccines
Track 3: Cellular and Molecular-Based Vaccines
Track 3-1
Peptide vaccines, DNA vaccines, cancer vaccines
Track 3-2
Design and development of novel vaccines
Track 3-3
Recombinant DNA vaccine technology
Track 3-4
Polio vaccines, HIV vaccines
Track 3-5
Development of vaccine for human papillomavirus
Track 3-6
Carbohydrate / polysaccharide vaccine technology
Track 4: Vaccines Against Infectious Diseases
Track 4-1
Anti-parasite vaccines
Track 4-2
Antiviral and antibacterial vaccines
Track 4-3
Biodefence vaccines: The filovirus experience
Track 4-4
Advance in novel pertussis vaccines
Track 4-5
Novel adjuvants
Track 4-6
Plant and animal based vaccines
Track 4-7
Biomarkers in vaccines
Track 4-8
Rotavirus vaccines
Track 4-9
Pneumococcal vaccines
Track 4-10
Emerging and re-emerging infectious disease vaccines
Track 4-11
Food safety vaccines, glyco-conjugate vaccines
Track 5: Manufacturing, Production, and Development of Vaccines
Track 5-1
Innovative techniques for the multi-product vaccine
Track 5-2
Robust and reproducible manufacturing techniques
Track 5-3
QA/QC strategies in vaccine development and production
Track 5-4
Technological improvements for downstream processing of vaccines
Track 5-5
Generation of vaccines using high-throughput micro bioreactors
Track 5-6
Mechanistic basic prophylactic and therapeutic vaccines
Track 6: Regulatory and Ethical Issues of Vaccines and Public Acceptance
Track 6-1
Risk assessment and management of vaccine usage
Track 6-2
Case studies for HIV and tropical diseases
Track 6-3
Personalized medicine development
Track 6-4
Current issues in vaccine communication, safety, and health policies
Track 6-5
Market trend and regulatory aspects of vaccine development and distribution
Track 6-6
Epidemiological studies and scientific assessment of vaccine adverse events
Track 7: Current Issues on Clinical Evaluation and Field Trials of Vaccines
Track 7-1
Validation and optimization of treatment strategies for new targets
Track 7-2
Vaccine trials: Clinical testing, defining efficacy endpoints, and confirmatory studies
Track 7-3
Genetic predictors of immune response
Track 7-4
Long term vaccine therapy for clonal exhaustion
Track 7-5
Surveillance of vaccine preventable diseases
Track 8: Modern Technologies in Vaccine Discovery and Development
Track 8-1
Vaccine development strategies for neurodegenerative disorders
Track 8-2
New developments in veterinary vaccines
Track 8-3
Vaccine approaches to immunotherapy and clinical trials
Track 8-4
Nanotechnology in vaccine delivery
Track 8-5
Novel discoveries in allergen vaccines
Track 8-6
Advances in the delivery methods for transcutaneous immunization
Track 9: Age-specific Immune Response to Vaccination
Track 9-1
Vaccination in pregnancy and newborns
Track 9-2
Status and impact of childhood and adolescent immunizations
Track 9-3
Vaccination in adults and older individuals: New perspectives
Track 9-4
Travel immunizations and safety issues
Track 9-5
Immunization in immunocompromised patients
Track 9-6
Challenges in implementing immunization programs and strategies to improve them